Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial, pt. 2
Prof. Gil Wolfe discusses who might and might not be good candidates for thymectomy for non-thymomatous myasthenia gravis in the second part of his interview with Dr. Ted Burns. Read the full study in...
17 Heinä 20193min
The full spectrum of epilepsies from SUDEP in the North American SUDEP Registry
Dr. Orrin Devinsky summarizes his paper on the full spectrum of epilepsies and the North American SUDEP Registry. Listen to this week's full podcast for the entire interview.
16 Heinä 20192min
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Prof. Gil Wolfe summarizes his findings from his study on the long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis. Read the paper ...
15 Heinä 20192min
Neurology Residency Programs & Training
Dr. Jeffrey Ratliff discusses neurology residency programs, training, and action by the consortium of residency program directors.
12 Heinä 20191min
MuSK Myasthenia Gravis
Dr. Ted Burns discusses clinical recognition and diagnosis of MuSK myasthenia gravis.
11 Heinä 20192min
Continuum Pearls: Pregnancy and Family Planning in Multiple Sclerosis, pt. 3
Dr. Annette Langer-Gould discusses pregnancy and family planning with MS in the third of a three-part series. To learn more, read the article "Pregnancy and Family Planning in Multiple Sclerosis" by D...
10 Heinä 20191min
Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
Dr. Franziska Hopfner talks about the main takeaways from her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
9 Heinä 20191min
First Cannabis-Derived Pharmaceutical
Dr. Jerzy Szaflarski talks about the FDA's approval of the first cannabis-derived pharmaceutical for the treatment of epilepsy and Lennox-Gastaut syndrome in particular. For more, read the full articl...
8 Heinä 20191min
